ArthroMeda was founded with the mission to revolutionize hip arthroplasty surgery through advanced technology. The company offers a patented sensor-based navigation system designed to enhance the precision and alignment of hip implants, thereby reducing the risk of implant failures and the need for costly revisions. ArthroMeda's core vision is to improve surgical outcomes and patient recovery times while addressing the growing demand in the joint replacement market, which is expected to reach $33 billion globally.
Notable affiliated individuals include Dr. Ward, an Attending Physician at New England Baptist Hospital and an Assistant Clinical Professor at Tufts University School of Medicine, Department of Orthopedic Surgery. ArthroMeda has achieved significant milestones, including the development of its proprietary ArthroSight-PS design. The company's impact is evident in its potential to reduce additional procedure time by 23 minutes compared to existing navigation systems, offering a cost-effective and efficient solution in orthopedic surgery.
